Immutep Ltd is a biotechnology company working primarily in the field of cancer immunotherapy.

Biotechnology

Immutep

Immutep's headquarters in Sydney, Australia

Marc Voigt

Frédéric Triebel

Christian Mueller

Deanne Miller

Martine J. Piccart

Martin Forster

Scott Antonia

Leisha A Emens

Hans Wildiers

Russell Howard

Lis Boyce

Salah-Eddin Al-Batran

Pete Meyers

This department manages and oversees clinical trials and research initiatives to ensure compliance and efficacy in drug development.

Clinical Research

The Clinical Operations team at Immutep is responsible for the planning, execution, and management of clinical trials related to cancer immunotherapy. This team oversees trial protocols, ensures compliance with regulatory standards, manages clinical supplies, and coordinates with contracts and vendors to facilitate the smooth operation of studies. Through their expertise, the team aims to drive innovative research and improve patient outcomes in cancer treatment.

Clinical Operations

This department focuses on identifying growth opportunities and building strategic partnerships to enhance the organization's market presence.

Business Development

This department is responsible for ensuring compliance with regulations and guidelines for clinical trials and medical writing.

Clinical Regulatory Affairs

This department provides strategic oversight and direction for medical practices and initiatives.

Medical Leadership

This department provides expert guidance and strategic advice to clients and stakeholders.

Immutep

Org chart

Board & advisors

Teams

Clinical Research

Clinical Operations

Business Development

Clinical Regulatory Affairs

Medical Leadership

Advisory Services

Offices

Immutep

Org chart

Board & advisors

Teams

Clinical Research

Clinical Operations

Business Development

Clinical Regulatory Affairs

Medical Leadership

Advisory Services

Offices

Related companies